FDA Inspection 1094298 — Agon Pharma Private Limited

Agon Pharma Private Limited — FEI 3007481629

The FDA completed an inspection of Agon Pharma Private Limited on June 13, 2019 in Pune. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 13, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pune (India)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
201221 CFR 211.188(b)Batch production and Batch Control Record Requirements
358221 CFR 211.105(a)Identification of containers, lines, equipment
430721 CFR 211.80(d)Status of Each Lot Identified